Calixte Nahomy, Brahmbhatt Jamin, Parekattil Sijo
South Lake Hospital, 1900 Don Wickham Drive, Clermont, FL 34711, USA.
Transl Androl Urol. 2017 Apr;6(2):252-257. doi: 10.21037/tau.2017.03.03.
Chronic testicular pain although becoming very common in our patient population poses a challenge to the physician, the patient and his family. The pathogenesis of chronic orchialgia (CO) is not well understood. The objective of this paper is to review the current literature on chronic testicular pain and its management and to propose an algorithm for its treatment. Abstracts, original papers and review articles were reviewed during a literature search using words such as testicular pain, CO, and microsurgical anatomy of spermatic cord. Chronic scrotal content pain (CSP) is a difficult condition to treat and could be idiopathic or secondary. Conservative therapy is the first line of treatment attempted to allow the patient to return to his routine activities. When conservative treatment fails, patients can now turn toward surgical options such as microsurgical denervation of the spermatic cord (MDSC) which has a success rate published in the 60-85% range and/or minimally invasive therapies such as microcryoablation of the spermatic cord, Botox or Amniofix injection. There is an increase in referrals for CO. The true pathogenesis is still unclear and the road to complete recovery is unsure for certain patients. This paper proposes an algorithm for the management of patients suffering with CO.
慢性睾丸疼痛在我们的患者群体中虽然变得非常常见,但对医生、患者及其家属来说都是一项挑战。慢性睾丸痛(CO)的发病机制尚未完全明了。本文的目的是回顾关于慢性睾丸疼痛及其治疗的当前文献,并提出一种治疗方案。在文献检索过程中,我们使用了诸如睾丸疼痛、CO以及精索显微外科解剖等词汇,对摘要、原创论文和综述文章进行了回顾。慢性阴囊内容物疼痛(CSP)是一种难以治疗的病症,可能是特发性的或继发性的。保守治疗是尝试让患者恢复日常活动的一线治疗方法。当保守治疗失败时,患者现在可以转向手术选择,如精索显微去神经术(MDSC),其成功率在60%至85%之间,和/或微创治疗,如精索微冷冻消融、肉毒杆菌毒素注射或羊膜修复注射。CO的转诊病例有所增加。真正的发病机制仍不清楚,对于某些患者来说,完全康复之路并不确定。本文提出了一种针对患有CO的患者的管理方案。